Regencell Bioscience
2 hedge funds and large institutions have $230K invested in Regencell Bioscience in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$224K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$6K |
Top Sellers
| 1 |
SSA
1
Schonfeld Strategic Advisors
New York
|
$0 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$0 |
| 3 |
3
Morgan Stanley
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $224K | +$224K | +259,008 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $6K | +$6K | +7,296 | New |
|
|
SSA
3
Schonfeld Strategic Advisors
New York
| – | -$231K | -387,600 | Closed |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| – | -$74K | -124,260 | Closed |
|
|
5
Morgan Stanley
New York
| – | -$11K | -19,114 | Closed |
|